{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:51Z","timestamp":1707525591920},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,14]]},"DOI":"10.7759\/cureus.50498","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T10:23:21Z","timestamp":1702549401000},"source":"Crossref","is-referenced-by-count":0,"title":["Unraveling Bacillus Calmette-Gu\u00e9rin (BCG) Therapy Side Effects in Bladder Cancer: A Tale of Triumph Over Treatment Challenges"],"prefix":"10.7759","author":[{"given":"Tomas","family":"Escobar Gil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar F","family":"Borja Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu Baker","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"22","author":"Lange C","year":"2022","unstructured":"Lange C, Aaby P, Behr MA, Donald PR, Kaufmann SH, Netea MG, Mandalakas AM. 100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin. Lancet Infect Dis. 2022, 22:E2-E12. 10.1016\/S1473-3099(21)00403-5","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis AT","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020, 324:1980-91. 10.1001\/jama.2020.17598","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab033","article-title":"Disseminated BCG infection after intravesical BCG immunotherapy of bladder cancer","volume":"114","author":"Ramalingam S","year":"2021","unstructured":"Ramalingam S, Gunasekaran K, Arora H, Muruganandam M, Nagaraju S, Padmanabhan P. Disseminated BCG infection after intravesical BCG immunotherapy of bladder cancer. QJM. 2021, 114:410-1. 10.1093\/qjmed\/hcab033","journal-title":"QJM"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110393","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han J","year":"2020","unstructured":"Han J, Gu X, Li Y, Wu Q. Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect. Biomed Pharmacother. 2020, 129:110393. 10.1016\/j.biopha.2020.110393","journal-title":"Biomed Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"Biot C","year":"2012","unstructured":"Biot C, Rentsch CA, Gsponer JR, et al.. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med. 2012, 4:137ra72. 10.1126\/scitranslmed.3003586","journal-title":"Sci Transl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2022.2118606","article-title":"Immunotherapy for bladder cancer: latest advances and ongoing clinical trials","volume":"51","author":"Ward Grados DF","year":"2022","unstructured":"Ward Grados DF, Ahmadi H, Griffith TS, Warlick CA. Immunotherapy for bladder cancer: latest advances and ongoing clinical trials. Immunol Invest. 2022, 51:2226-51. 10.1080\/08820139.2022.2118606","journal-title":"Immunol Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq002","article-title":"Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin used for immunotherapy in bladder cancer","volume":"52","author":"Watts MR","year":"2011","unstructured":"Watts MR, Taylor PC, Sintchenko V, et al.. Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin used for immunotherapy in bladder cancer. Clin Infect Dis. 2011, 52:86-8. 10.1093\/cid\/ciq002","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000381","article-title":"Re: disseminated mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer","volume":"202","author":"Chang SS","year":"2019","unstructured":"Chang SS. Re: disseminated mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer. J Urol. 2019, 202:457. 10.1097\/JU.0000000000000381","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2023.05.017","article-title":"Super acute-onset disseminated BCG infection: a case report","volume":"29","author":"Takase R","year":"2023","unstructured":"Takase R, Hagiya H, Fujimori T, et al.. Super acute-onset disseminated BCG infection: a case report. J Infect Chemother. 2023, 29:919-21. 10.1016\/j.jiac.2023.05.017","journal-title":"J Infect Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch J","year":"2021","unstructured":"Dobruch J, Oszczud\u0142owski M. Bladder cancer: current challenges and future directions. Medicina (Kaunas). 2021, 57:749. 10.3390\/medicina57080749","journal-title":"Medicina (Kaunas)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/208469-unraveling-bacillus-calmette-gurin-bcg-therapy-side-effects-in-bladder-cancer-a-tale-of-triumph-over-treatment-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:37Z","timestamp":1707509557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/208469-unraveling-bacillus-calmette-gurin-bcg-therapy-side-effects-in-bladder-cancer-a-tale-of-triumph-over-treatment-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.50498","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,14]]}}}